Literature DB >> 24164228

Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy.

Angélica Ferreira Oton-Leite1, Larissa Santana Arantes Elias, Marília Oliveira Morais, Juliana Castro Dourado Pinezi, Claudio Rodrigues Leles, Maria Alves Garcia Santos Silva, Elismauro Francisco Mendonça.   

Abstract

The aim of this study was to assess the effect of low level laser therapy on reducing the occurrence and severity of oral complications in patients with head and neck cancer undergoing radiotherapy. Sixty head and neck cancer outpatients from a cancer hospital receiving radiotherapy were selected and randomly assigned into two groups. The laser group was irradiated with an InGaAlP laser and the control received sham laser. The assessment of complications (oral mucositis, pain) was carried out one week after starting radiotherapy, and at the fifteenth and thirtieth sessions of radiotherapy. All patients from both groups showed some degree of oral mucositis. Better outcomes were observed in the laser group when compared with the control in the follow-up sessions, indicating lower degrees of oral mucositis, pain and higher salivary flow (p < .05). These findings support the use of laser therapy as an adjuvant treatment for the control of oral complications. ©2012 Special Care Dentistry Association and Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck cancer; laser therapy; oral mucositis; oral pain; xerostomia

Mesh:

Year:  2012        PMID: 24164228     DOI: 10.1111/j.1754-4505.2012.00303.x

Source DB:  PubMed          Journal:  Spec Care Dentist        ISSN: 0275-1879


  15 in total

1.  Is photobiomodulation therapy effective in reducing pain caused by toxicities related to head and neck cancer treatment? A systematic review.

Authors:  Mariana de Pauli Paglioni; Carolina Guimarães Bonfim Alves; Elisa Kauark Fontes; Marcio Ajudarte Lopes; Ana Carolina Prado Ribeiro; Thaís Bianca Brandão; Cesar Augusto Migliorati; Alan Roger Santos-Silva
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

2.  Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial.

Authors:  Daniella Ribeiro Naves Salvador; Danilo Figueiredo Soave; Nancy Tomoko Sacono; Eduardo Fernandes de Castro; Geisa Badauy Lauria Silva; Larissa Pereira E Silva; Tarcília Aparecida Silva; Marize Campos Valadares; Elismauro Francisco Mendonça; Aline Carvalho Batista
Journal:  Lasers Med Sci       Date:  2017-06-29       Impact factor: 3.161

3.  Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  Yehuda Zadik; Praveen R Arany; Eduardo Rodrigues Fregnani; Paolo Bossi; Héliton Spindola Antunes; René-Jean Bensadoun; Luiz Alcino Gueiros; Alessandra Majorana; Raj G Nair; Vinisha Ranna; Wim J E Tissing; Anusha Vaddi; Rachel Lubart; Cesar Augusto Migliorati; Rajesh V Lalla; Karis Kin Fong Cheng; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

Review 4.  Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.

Authors:  Judith A E M Zecha; Judith E Raber-Durlacher; Raj G Nair; Joel B Epstein; Sharon Elad; Michael R Hamblin; Andrei Barasch; Cesar A Migliorati; Dan M J Milstein; Marie-Thérèse Genot; Liset Lansaat; Ron van der Brink; Josep Arnabat-Dominguez; Lisette van der Molen; Irene Jacobi; Judi van Diessen; Jan de Lange; Ludi E Smeele; Mark M Schubert; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

5.  Does low-level laser therapy affect the survival of patients with head and neck cancer?

Authors:  Rene Fischlechner; Barbara Kofler; Volker Hans Schartinger; Jozsef Dudas; Herbert Riechelmann
Journal:  Lasers Med Sci       Date:  2020-06-25       Impact factor: 3.161

6.  Clinical use of photobiomodulation as a supportive care during radiation therapy.

Authors:  Guillaume Klausner; Idriss Troussier; Charles-Henry Canova; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2022-01       Impact factor: 3.603

7.  Efficacy of Photobiomodulation in Reducing Symptomatology and Improving the Quality of Life in Patients with Xerostomia and Hyposalivation: A Randomized Controlled Trial.

Authors:  Alba Ferrandez-Pujante; Eduardo Pons-Fuster; Pia López-Jornet
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

8.  Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.

Authors:  Joel B Epstein; Judith E Raber-Durlacher; Michael Lill; Yuliya P L Linhares; Jerry Chang; Andrei Barasch; Romée I C Slief; Margot Geuke; Judith A E M Zecha; Dan M J Milstein; D Tzachanis
Journal:  Support Care Cancer       Date:  2016-09-21       Impact factor: 3.603

9.  The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients.

Authors:  Marilia Oliveira Morais; Marcela Ramos Abrahão Elias; Cláudio Rodrigues Leles; Juliana Castro Dourado Pinezi; Elismauro Francisco Mendonça
Journal:  Support Care Cancer       Date:  2015-09-26       Impact factor: 3.603

10.  Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice.

Authors:  Jean Pierre Schatzmann Peron; Auriléia Aparecida de Brito; Mayra Pelatti; Wesley Nogueira Brandão; Luana Beatriz Vitoretti; Flávia Regina Greiffo; Elaine Cristina da Silveira; Manuel Carneiro Oliveira-Junior; Mariangela Maluf; Lucila Evangelista; Silvio Halpern; Marcelo Gil Nisenbaum; Paulo Perin; Carlos Eduardo Czeresnia; Niels Olsen Saraiva Câmara; Flávio Aimbire; Rodolfo de Paula Vieira; Mayana Zatz; Ana Paula Ligeiro de Oliveira
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.